Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension

Stopped early · Phase 1

Conditions studied: Hemodialysis, Hypotension

In brief

Low blood pressure (hypotension) during dialysis afflicts approximately 25% of hemodialysis patients. In this pilot study, we will evaluate the safety and effects of individualizing the sodium concentration in the dialysate according to the patient's own plasma sodium levels. We hypothesize that patients will have less thirst and less weight gain during the intervention leading to easier fluid removal and less episodes of hypotension.

Key facts

Study ID

NCT00237783

Run by

Yale University

People needed

4

Starts

2005-10-01

Expected to finish

2008-10-01

Last updated by the study team

2016-07-26

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Hemodialysis patients with intradialytic hypotension

You may not qualify if…

• Atrial fibrillation
• Bilateral upper extremity arteriovenous access
• Average plasma sodium >139

Where it is running

• VA Connecticut Healthcare System — West Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.